MET and gastric carcinoma: c-MET overexpression and amplification have been reported in 18-82% of gastric carcinoma which studied by immunofluorescence[12], immunohistochemistry (IHC) [17-27], reverse transcription polymerase chain reaction (RT-PCR) [17,28], Northern blot analysis [12] and Southern blot analysis [19].